Total: 2 |
|
PMID (PMCID) | ||
---|---|---|
27128852 |
FEMALE | |
Anti-coagulant therapy with dabigatran for cystic fibrosis patients. | ||
Bansal M, Ren CL. Pediatr Pulmonol. 2016;51(8):E29-30. |
||
Patients with cystic fibrosis (CF) are at increased risk of venous thromboembolism, especially in association with central venous catheter use. | ||
9039250 |
FEMALE | Adult |
Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis. | ||
Yung B, Elborn JS, Campbell IA, Summers Y, Beckles M, Woodcock AA. Thorax. 1997;52(1):98-9. |
||
Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis. |